nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—CYP3A4—type 2 diabetes mellitus	0.371	1	CbGaD
Darunavir—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0607	0.152	CbGbCtD
Darunavir—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0541	0.136	CbGbCtD
Darunavir—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0495	0.124	CbGbCtD
Darunavir—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0433	0.109	CbGbCtD
Darunavir—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0391	0.0982	CbGbCtD
Darunavir—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0296	0.0744	CbGbCtD
Darunavir—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0284	0.0713	CbGbCtD
Darunavir—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0284	0.0713	CbGbCtD
Darunavir—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0269	0.0675	CbGbCtD
Darunavir—CYP3A4—Glyburide—type 2 diabetes mellitus	0.02	0.0503	CbGbCtD
Darunavir—CYP3A4—Losartan—type 2 diabetes mellitus	0.0183	0.046	CbGbCtD
Darunavir—Fosamprenavir—CYP3A4—type 2 diabetes mellitus	0.00185	0.707	CrCbGaD
Darunavir—Amprenavir—CYP3A4—type 2 diabetes mellitus	0.000768	0.293	CrCbGaD
Darunavir—Flushing—Ramipril—type 2 diabetes mellitus	8.76e-05	0.000384	CcSEcCtD
Darunavir—Angioedema—Losartan—type 2 diabetes mellitus	8.76e-05	0.000383	CcSEcCtD
Darunavir—Insomnia—Valsartan—type 2 diabetes mellitus	8.75e-05	0.000383	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	8.7e-05	0.000381	CcSEcCtD
Darunavir—Paraesthesia—Valsartan—type 2 diabetes mellitus	8.68e-05	0.00038	CcSEcCtD
Darunavir—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	8.67e-05	0.00038	CcSEcCtD
Darunavir—Chest pain—Irbesartan—type 2 diabetes mellitus	8.67e-05	0.00038	CcSEcCtD
Darunavir—Myalgia—Irbesartan—type 2 diabetes mellitus	8.67e-05	0.00038	CcSEcCtD
Darunavir—Arthralgia—Irbesartan—type 2 diabetes mellitus	8.67e-05	0.00038	CcSEcCtD
Darunavir—Shock—Metformin—type 2 diabetes mellitus	8.66e-05	0.000379	CcSEcCtD
Darunavir—Insomnia—Orlistat—type 2 diabetes mellitus	8.64e-05	0.000378	CcSEcCtD
Darunavir—Malaise—Losartan—type 2 diabetes mellitus	8.64e-05	0.000378	CcSEcCtD
Darunavir—Anxiety—Irbesartan—type 2 diabetes mellitus	8.64e-05	0.000378	CcSEcCtD
Darunavir—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.64e-05	0.000378	CcSEcCtD
Darunavir—Nervous system disorder—Metformin—type 2 diabetes mellitus	8.64e-05	0.000378	CcSEcCtD
Darunavir—Thrombocytopenia—Metformin—type 2 diabetes mellitus	8.62e-05	0.000378	CcSEcCtD
Darunavir—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.62e-05	0.000378	CcSEcCtD
Darunavir—Vertigo—Losartan—type 2 diabetes mellitus	8.61e-05	0.000377	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	8.61e-05	0.000377	CcSEcCtD
Darunavir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.61e-05	0.000377	CcSEcCtD
Darunavir—Somnolence—Valsartan—type 2 diabetes mellitus	8.6e-05	0.000376	CcSEcCtD
Darunavir—Syncope—Losartan—type 2 diabetes mellitus	8.59e-05	0.000376	CcSEcCtD
Darunavir—Paraesthesia—Orlistat—type 2 diabetes mellitus	8.58e-05	0.000376	CcSEcCtD
Darunavir—Leukopenia—Losartan—type 2 diabetes mellitus	8.58e-05	0.000376	CcSEcCtD
Darunavir—Discomfort—Irbesartan—type 2 diabetes mellitus	8.56e-05	0.000375	CcSEcCtD
Darunavir—Skin disorder—Metformin—type 2 diabetes mellitus	8.55e-05	0.000375	CcSEcCtD
Darunavir—Immune system disorder—Ramipril—type 2 diabetes mellitus	8.52e-05	0.000373	CcSEcCtD
Darunavir—Hyperhidrosis—Metformin—type 2 diabetes mellitus	8.51e-05	0.000373	CcSEcCtD
Darunavir—Dyspepsia—Valsartan—type 2 diabetes mellitus	8.51e-05	0.000373	CcSEcCtD
Darunavir—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	8.51e-05	0.000373	CcSEcCtD
Darunavir—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.48e-05	0.000371	CcSEcCtD
Darunavir—Dry mouth—Irbesartan—type 2 diabetes mellitus	8.48e-05	0.000371	CcSEcCtD
Darunavir—Palpitations—Losartan—type 2 diabetes mellitus	8.47e-05	0.000371	CcSEcCtD
Darunavir—Nausea—Glimepiride—type 2 diabetes mellitus	8.44e-05	0.00037	CcSEcCtD
Darunavir—Loss of consciousness—Losartan—type 2 diabetes mellitus	8.42e-05	0.000369	CcSEcCtD
Darunavir—Nausea—Sitagliptin—type 2 diabetes mellitus	8.41e-05	0.000369	CcSEcCtD
Darunavir—Dyspepsia—Orlistat—type 2 diabetes mellitus	8.41e-05	0.000368	CcSEcCtD
Darunavir—Asthenia—Glyburide—type 2 diabetes mellitus	8.41e-05	0.000368	CcSEcCtD
Darunavir—Decreased appetite—Valsartan—type 2 diabetes mellitus	8.41e-05	0.000368	CcSEcCtD
Darunavir—Anorexia—Metformin—type 2 diabetes mellitus	8.39e-05	0.000368	CcSEcCtD
Darunavir—Cough—Losartan—type 2 diabetes mellitus	8.36e-05	0.000366	CcSEcCtD
Darunavir—Urticaria—Gliclazide—type 2 diabetes mellitus	8.36e-05	0.000366	CcSEcCtD
Darunavir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	8.35e-05	0.000366	CcSEcCtD
Darunavir—Alopecia—Ramipril—type 2 diabetes mellitus	8.34e-05	0.000365	CcSEcCtD
Darunavir—Fatigue—Valsartan—type 2 diabetes mellitus	8.34e-05	0.000365	CcSEcCtD
Darunavir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	8.32e-05	0.000364	CcSEcCtD
Darunavir—Body temperature increased—Gliclazide—type 2 diabetes mellitus	8.32e-05	0.000364	CcSEcCtD
Darunavir—Decreased appetite—Orlistat—type 2 diabetes mellitus	8.31e-05	0.000364	CcSEcCtD
Darunavir—Pruritus—Glyburide—type 2 diabetes mellitus	8.29e-05	0.000363	CcSEcCtD
Darunavir—Mental disorder—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000362	CcSEcCtD
Darunavir—Constipation—Valsartan—type 2 diabetes mellitus	8.27e-05	0.000362	CcSEcCtD
Darunavir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	8.25e-05	0.000361	CcSEcCtD
Darunavir—Fatigue—Orlistat—type 2 diabetes mellitus	8.24e-05	0.000361	CcSEcCtD
Darunavir—Malnutrition—Ramipril—type 2 diabetes mellitus	8.22e-05	0.00036	CcSEcCtD
Darunavir—Erythema—Ramipril—type 2 diabetes mellitus	8.22e-05	0.00036	CcSEcCtD
Darunavir—Shock—Irbesartan—type 2 diabetes mellitus	8.18e-05	0.000358	CcSEcCtD
Darunavir—Pain—Orlistat—type 2 diabetes mellitus	8.17e-05	0.000358	CcSEcCtD
Darunavir—Myalgia—Losartan—type 2 diabetes mellitus	8.16e-05	0.000357	CcSEcCtD
Darunavir—Chest pain—Losartan—type 2 diabetes mellitus	8.16e-05	0.000357	CcSEcCtD
Darunavir—Arthralgia—Losartan—type 2 diabetes mellitus	8.16e-05	0.000357	CcSEcCtD
Darunavir—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.15e-05	0.000357	CcSEcCtD
Darunavir—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.15e-05	0.000357	CcSEcCtD
Darunavir—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	8.14e-05	0.000356	CcSEcCtD
Darunavir—Anxiety—Losartan—type 2 diabetes mellitus	8.13e-05	0.000356	CcSEcCtD
Darunavir—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.11e-05	0.000355	CcSEcCtD
Darunavir—Rash—Bromocriptine—type 2 diabetes mellitus	8.08e-05	0.000354	CcSEcCtD
Darunavir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.08e-05	0.000354	CcSEcCtD
Darunavir—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.07e-05	0.000354	CcSEcCtD
Darunavir—Discomfort—Losartan—type 2 diabetes mellitus	8.06e-05	0.000353	CcSEcCtD
Darunavir—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.05e-05	0.000352	CcSEcCtD
Darunavir—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.03e-05	0.000352	CcSEcCtD
Darunavir—Headache—Bromocriptine—type 2 diabetes mellitus	8.03e-05	0.000352	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.02e-05	0.000351	CcSEcCtD
Darunavir—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.02e-05	0.000351	CcSEcCtD
Darunavir—Dry mouth—Losartan—type 2 diabetes mellitus	7.98e-05	0.000349	CcSEcCtD
Darunavir—Anorexia—Irbesartan—type 2 diabetes mellitus	7.92e-05	0.000347	CcSEcCtD
Darunavir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.91e-05	0.000346	CcSEcCtD
Darunavir—Paraesthesia—Metformin—type 2 diabetes mellitus	7.91e-05	0.000346	CcSEcCtD
Darunavir—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.9e-05	0.000346	CcSEcCtD
Darunavir—Confusional state—Losartan—type 2 diabetes mellitus	7.89e-05	0.000345	CcSEcCtD
Darunavir—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7.87e-05	0.000345	CcSEcCtD
Darunavir—Dyspnoea—Metformin—type 2 diabetes mellitus	7.85e-05	0.000344	CcSEcCtD
Darunavir—Somnolence—Metformin—type 2 diabetes mellitus	7.83e-05	0.000343	CcSEcCtD
Darunavir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.81e-05	0.000342	CcSEcCtD
Darunavir—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.75e-05	0.00034	CcSEcCtD
Darunavir—Dyspepsia—Metformin—type 2 diabetes mellitus	7.75e-05	0.000339	CcSEcCtD
Darunavir—Shock—Losartan—type 2 diabetes mellitus	7.69e-05	0.000337	CcSEcCtD
Darunavir—Urticaria—Valsartan—type 2 diabetes mellitus	7.68e-05	0.000336	CcSEcCtD
Darunavir—Nervous system disorder—Losartan—type 2 diabetes mellitus	7.67e-05	0.000336	CcSEcCtD
Darunavir—Thrombocytopenia—Losartan—type 2 diabetes mellitus	7.66e-05	0.000335	CcSEcCtD
Darunavir—Decreased appetite—Metformin—type 2 diabetes mellitus	7.65e-05	0.000335	CcSEcCtD
Darunavir—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.64e-05	0.000335	CcSEcCtD
Darunavir—Tachycardia—Losartan—type 2 diabetes mellitus	7.63e-05	0.000334	CcSEcCtD
Darunavir—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	7.62e-05	0.000334	CcSEcCtD
Darunavir—Nausea—Bromocriptine—type 2 diabetes mellitus	7.62e-05	0.000334	CcSEcCtD
Darunavir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	7.6e-05	0.000333	CcSEcCtD
Darunavir—Fatigue—Metformin—type 2 diabetes mellitus	7.59e-05	0.000332	CcSEcCtD
Darunavir—Urticaria—Orlistat—type 2 diabetes mellitus	7.59e-05	0.000332	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000332	CcSEcCtD
Darunavir—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.56e-05	0.000331	CcSEcCtD
Darunavir—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.55e-05	0.000331	CcSEcCtD
Darunavir—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.55e-05	0.000331	CcSEcCtD
Darunavir—Asthenia—Gliclazide—type 2 diabetes mellitus	7.55e-05	0.000331	CcSEcCtD
Darunavir—Agitation—Ramipril—type 2 diabetes mellitus	7.55e-05	0.000331	CcSEcCtD
Darunavir—Constipation—Metformin—type 2 diabetes mellitus	7.53e-05	0.00033	CcSEcCtD
Darunavir—Angioedema—Ramipril—type 2 diabetes mellitus	7.51e-05	0.000329	CcSEcCtD
Darunavir—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000327	CcSEcCtD
Darunavir—Anorexia—Losartan—type 2 diabetes mellitus	7.45e-05	0.000326	CcSEcCtD
Darunavir—Vomiting—Glyburide—type 2 diabetes mellitus	7.45e-05	0.000326	CcSEcCtD
Darunavir—Pruritus—Gliclazide—type 2 diabetes mellitus	7.45e-05	0.000326	CcSEcCtD
Darunavir—Malaise—Ramipril—type 2 diabetes mellitus	7.41e-05	0.000325	CcSEcCtD
Darunavir—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.41e-05	0.000324	CcSEcCtD
Darunavir—Rash—Glyburide—type 2 diabetes mellitus	7.39e-05	0.000324	CcSEcCtD
Darunavir—Somnolence—Irbesartan—type 2 diabetes mellitus	7.39e-05	0.000324	CcSEcCtD
Darunavir—Dermatitis—Glyburide—type 2 diabetes mellitus	7.38e-05	0.000323	CcSEcCtD
Darunavir—Vertigo—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000323	CcSEcCtD
Darunavir—Syncope—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000323	CcSEcCtD
Darunavir—Leukopenia—Ramipril—type 2 diabetes mellitus	7.35e-05	0.000322	CcSEcCtD
Darunavir—Headache—Glyburide—type 2 diabetes mellitus	7.34e-05	0.000322	CcSEcCtD
Darunavir—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.31e-05	0.00032	CcSEcCtD
Darunavir—Palpitations—Ramipril—type 2 diabetes mellitus	7.26e-05	0.000318	CcSEcCtD
Darunavir—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.26e-05	0.000318	CcSEcCtD
Darunavir—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000316	CcSEcCtD
Darunavir—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.22e-05	0.000316	CcSEcCtD
Darunavir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.2e-05	0.000315	CcSEcCtD
Darunavir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.2e-05	0.000315	CcSEcCtD
Darunavir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.17e-05	0.000314	CcSEcCtD
Darunavir—Cough—Ramipril—type 2 diabetes mellitus	7.17e-05	0.000314	CcSEcCtD
Darunavir—Fatigue—Irbesartan—type 2 diabetes mellitus	7.16e-05	0.000314	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.12e-05	0.000312	CcSEcCtD
Darunavir—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.12e-05	0.000312	CcSEcCtD
Darunavir—Convulsion—Ramipril—type 2 diabetes mellitus	7.12e-05	0.000312	CcSEcCtD
Darunavir—Constipation—Irbesartan—type 2 diabetes mellitus	7.11e-05	0.000311	CcSEcCtD
Darunavir—Pain—Irbesartan—type 2 diabetes mellitus	7.11e-05	0.000311	CcSEcCtD
Darunavir—Insomnia—Losartan—type 2 diabetes mellitus	7.07e-05	0.00031	CcSEcCtD
Darunavir—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.04e-05	0.000308	CcSEcCtD
Darunavir—Paraesthesia—Losartan—type 2 diabetes mellitus	7.02e-05	0.000308	CcSEcCtD
Darunavir—Urticaria—Metformin—type 2 diabetes mellitus	7e-05	0.000306	CcSEcCtD
Darunavir—Arthralgia—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000306	CcSEcCtD
Darunavir—Chest pain—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000306	CcSEcCtD
Darunavir—Myalgia—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000306	CcSEcCtD
Darunavir—Dyspnoea—Losartan—type 2 diabetes mellitus	6.97e-05	0.000305	CcSEcCtD
Darunavir—Anxiety—Ramipril—type 2 diabetes mellitus	6.97e-05	0.000305	CcSEcCtD
Darunavir—Nausea—Glyburide—type 2 diabetes mellitus	6.96e-05	0.000305	CcSEcCtD
Darunavir—Abdominal pain—Metformin—type 2 diabetes mellitus	6.96e-05	0.000305	CcSEcCtD
Darunavir—Dizziness—Gliclazide—type 2 diabetes mellitus	6.96e-05	0.000305	CcSEcCtD
Darunavir—Somnolence—Losartan—type 2 diabetes mellitus	6.95e-05	0.000304	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	6.95e-05	0.000304	CcSEcCtD
Darunavir—Asthenia—Valsartan—type 2 diabetes mellitus	6.94e-05	0.000304	CcSEcCtD
Darunavir—Discomfort—Ramipril—type 2 diabetes mellitus	6.91e-05	0.000303	CcSEcCtD
Darunavir—Dyspepsia—Losartan—type 2 diabetes mellitus	6.88e-05	0.000301	CcSEcCtD
Darunavir—Asthenia—Orlistat—type 2 diabetes mellitus	6.86e-05	0.0003	CcSEcCtD
Darunavir—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.85e-05	0.0003	CcSEcCtD
Darunavir—Pruritus—Valsartan—type 2 diabetes mellitus	6.84e-05	0.0003	CcSEcCtD
Darunavir—Dry mouth—Ramipril—type 2 diabetes mellitus	6.84e-05	0.0003	CcSEcCtD
Darunavir—Decreased appetite—Losartan—type 2 diabetes mellitus	6.8e-05	0.000298	CcSEcCtD
Darunavir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.79e-05	0.000298	CcSEcCtD
Darunavir—Confusional state—Ramipril—type 2 diabetes mellitus	6.76e-05	0.000296	CcSEcCtD
Darunavir—Pruritus—Orlistat—type 2 diabetes mellitus	6.76e-05	0.000296	CcSEcCtD
Darunavir—Fatigue—Losartan—type 2 diabetes mellitus	6.74e-05	0.000295	CcSEcCtD
Darunavir—Vomiting—Gliclazide—type 2 diabetes mellitus	6.69e-05	0.000293	CcSEcCtD
Darunavir—Constipation—Losartan—type 2 diabetes mellitus	6.69e-05	0.000293	CcSEcCtD
Darunavir—Pain—Losartan—type 2 diabetes mellitus	6.69e-05	0.000293	CcSEcCtD
Darunavir—Rash—Gliclazide—type 2 diabetes mellitus	6.64e-05	0.000291	CcSEcCtD
Darunavir—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.63e-05	0.00029	CcSEcCtD
Darunavir—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.62e-05	0.00029	CcSEcCtD
Darunavir—Urticaria—Irbesartan—type 2 diabetes mellitus	6.6e-05	0.000289	CcSEcCtD
Darunavir—Shock—Ramipril—type 2 diabetes mellitus	6.6e-05	0.000289	CcSEcCtD
Darunavir—Headache—Gliclazide—type 2 diabetes mellitus	6.59e-05	0.000289	CcSEcCtD
Darunavir—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.58e-05	0.000288	CcSEcCtD
Darunavir—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.57e-05	0.000288	CcSEcCtD
Darunavir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.57e-05	0.000288	CcSEcCtD
Darunavir—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	6.57e-05	0.000288	CcSEcCtD
Darunavir—Tachycardia—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000287	CcSEcCtD
Darunavir—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.54e-05	0.000286	CcSEcCtD
Darunavir—Skin disorder—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000285	CcSEcCtD
Darunavir—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.48e-05	0.000284	CcSEcCtD
Darunavir—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.44e-05	0.000282	CcSEcCtD
Darunavir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.39e-05	0.00028	CcSEcCtD
Darunavir—Dizziness—Valsartan—type 2 diabetes mellitus	6.39e-05	0.00028	CcSEcCtD
Darunavir—Anorexia—Ramipril—type 2 diabetes mellitus	6.39e-05	0.00028	CcSEcCtD
Darunavir—Dizziness—Orlistat—type 2 diabetes mellitus	6.32e-05	0.000277	CcSEcCtD
Darunavir—Asthenia—Metformin—type 2 diabetes mellitus	6.32e-05	0.000277	CcSEcCtD
Darunavir—Nausea—Gliclazide—type 2 diabetes mellitus	6.25e-05	0.000274	CcSEcCtD
Darunavir—Pruritus—Metformin—type 2 diabetes mellitus	6.23e-05	0.000273	CcSEcCtD
Darunavir—Urticaria—Losartan—type 2 diabetes mellitus	6.21e-05	0.000272	CcSEcCtD
Darunavir—Abdominal pain—Losartan—type 2 diabetes mellitus	6.18e-05	0.000271	CcSEcCtD
Darunavir—Body temperature increased—Losartan—type 2 diabetes mellitus	6.18e-05	0.000271	CcSEcCtD
Darunavir—Vomiting—Valsartan—type 2 diabetes mellitus	6.15e-05	0.000269	CcSEcCtD
Darunavir—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.12e-05	0.000268	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000268	CcSEcCtD
Darunavir—Rash—Valsartan—type 2 diabetes mellitus	6.1e-05	0.000267	CcSEcCtD
Darunavir—Dermatitis—Valsartan—type 2 diabetes mellitus	6.09e-05	0.000267	CcSEcCtD
Darunavir—Vomiting—Orlistat—type 2 diabetes mellitus	6.07e-05	0.000266	CcSEcCtD
Darunavir—Insomnia—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000266	CcSEcCtD
Darunavir—Headache—Valsartan—type 2 diabetes mellitus	6.06e-05	0.000265	CcSEcCtD
Darunavir—Diarrhoea—Metformin—type 2 diabetes mellitus	6.02e-05	0.000264	CcSEcCtD
Darunavir—Rash—Orlistat—type 2 diabetes mellitus	6.02e-05	0.000264	CcSEcCtD
Darunavir—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000264	CcSEcCtD
Darunavir—Dermatitis—Orlistat—type 2 diabetes mellitus	6.02e-05	0.000264	CcSEcCtD
Darunavir—Headache—Orlistat—type 2 diabetes mellitus	5.99e-05	0.000262	CcSEcCtD
Darunavir—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.98e-05	0.000262	CcSEcCtD
Darunavir—Asthenia—Irbesartan—type 2 diabetes mellitus	5.96e-05	0.000261	CcSEcCtD
Darunavir—Somnolence—Ramipril—type 2 diabetes mellitus	5.96e-05	0.000261	CcSEcCtD
Darunavir—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.9e-05	0.000259	CcSEcCtD
Darunavir—Pruritus—Irbesartan—type 2 diabetes mellitus	5.88e-05	0.000257	CcSEcCtD
Darunavir—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000255	CcSEcCtD
Darunavir—Dizziness—Metformin—type 2 diabetes mellitus	5.82e-05	0.000255	CcSEcCtD
Darunavir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.79e-05	0.000254	CcSEcCtD
Darunavir—Fatigue—Ramipril—type 2 diabetes mellitus	5.78e-05	0.000253	CcSEcCtD
Darunavir—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.76e-05	0.000252	CcSEcCtD
Darunavir—Nausea—Valsartan—type 2 diabetes mellitus	5.74e-05	0.000252	CcSEcCtD
Darunavir—Constipation—Ramipril—type 2 diabetes mellitus	5.73e-05	0.000251	CcSEcCtD
Darunavir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.69e-05	0.000249	CcSEcCtD
Darunavir—Nausea—Orlistat—type 2 diabetes mellitus	5.68e-05	0.000249	CcSEcCtD
Darunavir—Asthenia—Losartan—type 2 diabetes mellitus	5.61e-05	0.000246	CcSEcCtD
Darunavir—Vomiting—Metformin—type 2 diabetes mellitus	5.6e-05	0.000245	CcSEcCtD
Darunavir—Rash—Metformin—type 2 diabetes mellitus	5.55e-05	0.000243	CcSEcCtD
Darunavir—Dermatitis—Metformin—type 2 diabetes mellitus	5.55e-05	0.000243	CcSEcCtD
Darunavir—Pruritus—Losartan—type 2 diabetes mellitus	5.53e-05	0.000242	CcSEcCtD
Darunavir—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.53e-05	0.000242	CcSEcCtD
Darunavir—Headache—Metformin—type 2 diabetes mellitus	5.52e-05	0.000242	CcSEcCtD
Darunavir—Dizziness—Irbesartan—type 2 diabetes mellitus	5.49e-05	0.000241	CcSEcCtD
Darunavir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.48e-05	0.00024	CcSEcCtD
Darunavir—Diarrhoea—Losartan—type 2 diabetes mellitus	5.35e-05	0.000234	CcSEcCtD
Darunavir—Urticaria—Ramipril—type 2 diabetes mellitus	5.33e-05	0.000233	CcSEcCtD
Darunavir—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.3e-05	0.000232	CcSEcCtD
Darunavir—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.3e-05	0.000232	CcSEcCtD
Darunavir—Vomiting—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.000231	CcSEcCtD
Darunavir—Rash—Irbesartan—type 2 diabetes mellitus	5.24e-05	0.000229	CcSEcCtD
Darunavir—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.23e-05	0.000229	CcSEcCtD
Darunavir—Nausea—Metformin—type 2 diabetes mellitus	5.23e-05	0.000229	CcSEcCtD
Darunavir—Headache—Irbesartan—type 2 diabetes mellitus	5.21e-05	0.000228	CcSEcCtD
Darunavir—Dizziness—Losartan—type 2 diabetes mellitus	5.17e-05	0.000226	CcSEcCtD
Darunavir—Vomiting—Losartan—type 2 diabetes mellitus	4.97e-05	0.000218	CcSEcCtD
Darunavir—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000216	CcSEcCtD
Darunavir—Nausea—Irbesartan—type 2 diabetes mellitus	4.94e-05	0.000216	CcSEcCtD
Darunavir—Rash—Losartan—type 2 diabetes mellitus	4.93e-05	0.000216	CcSEcCtD
Darunavir—Dermatitis—Losartan—type 2 diabetes mellitus	4.93e-05	0.000216	CcSEcCtD
Darunavir—Headache—Losartan—type 2 diabetes mellitus	4.9e-05	0.000215	CcSEcCtD
Darunavir—Asthenia—Ramipril—type 2 diabetes mellitus	4.81e-05	0.000211	CcSEcCtD
Darunavir—Pruritus—Ramipril—type 2 diabetes mellitus	4.74e-05	0.000208	CcSEcCtD
Darunavir—Nausea—Losartan—type 2 diabetes mellitus	4.65e-05	0.000203	CcSEcCtD
Darunavir—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.59e-05	0.000201	CcSEcCtD
Darunavir—Dizziness—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000194	CcSEcCtD
Darunavir—Vomiting—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000187	CcSEcCtD
Darunavir—Rash—Ramipril—type 2 diabetes mellitus	4.23e-05	0.000185	CcSEcCtD
Darunavir—Dermatitis—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000185	CcSEcCtD
Darunavir—Headache—Ramipril—type 2 diabetes mellitus	4.2e-05	0.000184	CcSEcCtD
Darunavir—Nausea—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000174	CcSEcCtD
